课题基金 / 基金详情

The Role of Shear Stress in Heart Failure

The Role of Shear Stress in Heart Failure
剪切应力在心力衰竭中的作用
批准号:
8213670
负责人:
GHASSAN S KASSAB
金额:
$37.02万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-02-01 至 2014-01-31

项目摘要

项目成果

GHASSAN S KASSAB的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): There is no doubt that the incidence of congestive heart failure (CHF) in the Western world is increasing as the population ages. The NHLBI has estimated that more than 2 million Americans have heart failure, with about half a million new cases diagnosed each year. The general objective of this proposal is to understand the role of vascular oxidative stress in CHF. The central hypothesis is that the reduced wall shear stress (WSS) in the microcirculation and reverse flow in the larger vessels will increase O2- production largely mediated by the NADPH oxidase system and hence reduce the vascular bioavailability of NO. This upregulation of NADPH oxidase is thought to be mediated through changes in endothelial cytoskeletal loading and deformation. To test this and other hypotheses, we set the following five Specific Aims: 1) To document and state the physical loading (blood flow, pressure and WSS) acting on the blood vessel endothelium in awake, free ranging animals precisely and analytically during the progression of CHF; 2) To identify the role of low and negative WSS determined in Aim 1 as the initial stimuli for O2- production in ex vivo vessels during acute flow reduction and flow reversal; 3) To establish the remodeling of the balance between NO and O2- chronically during the progression of HF due to reduced flow in the microcirculation and increased flow reversal in the macrocirculation identified in Aims 1 and 2; 4) To elucidate the role of NADPH oxide as well as other regulatory enzymes for NO (eNOS) and O2- dismutase (SOD) in limiting NO bioavailability in Aim 3; and 5) To quantify the endothelial and smooth muscle cell dysfunction of blood vessels due to the oxidative imbalance in Aims 2-4. The recorded in vivo blood pressure, flow and WSS data will be characterized with the empirical model decomposition method during the progression of CHF. The hemodynamic measurements will be correlated with the production of NO metabolites and expression of eNOS and SOD. The contribution of this project is to mathematically characterize the non-stationary, nonlinear, and stochastic features of the blood flow and blood pressure, the shear stress acting on vascular endothelial cells, and to show how escalation of low and negative WSS can have a detrimental effect on endothelial function, superoxide production, SOD and eNOS expression.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1115/1.4000085
发表时间: 2009-11
期刊: Journal of biomechanical engineering
影响因子: --
作者: [Wang C, Kassab GS]
通讯作者: Kassab GS
Extent of load-independence of pressure-normalized stress in swine.
猪的压力归一化应激与负荷无关的程度。
DOI: 10.1177/1535370213494548
发表时间: 2013
期刊: Experimental biology and medicine (Maywood, N.J.)
影响因子: --
作者: [Jia,Xinwei, Choy,JennyS, Zhang,Zhen-Du, Svendsen,Mark, Zhong,Liang, Tan,RuS, Kassab,GhassanS]
通讯作者: Kassab,GhassanS
DOI: 10.1152/japplphysiol.01356.2009
发表时间: 2010-12
期刊: Journal of applied physiology
影响因子: 3.3
作者: [Hai Zheng;Yunlong Huo;M. Svendsen;G. Kassab]
通讯作者: Hai Zheng;Yunlong Huo;M. Svendsen;G. Kassab
Bi-ventricular pacing improves pump function only with adequate myocardial perfusion in canine hearts with pseudo-left bundle branch block.
只有在患有假性左束支传导阻滞的犬心脏中有足够的心肌灌注时,双心室起搏才能改善泵功能。
DOI: 10.1258/ebm.2012.012023
发表时间: 2012
期刊: Experimental biology and medicine (Maywood, N.J.)
影响因子: --
作者: [Svendsen,Mark, Prinzen,FritsW, Das,MithileshK, Berwick,Zachary, Rybka,Matthew, Tune,JohnathanD, Combs,William, Berbari,EdwardJ, Kassab,GhassanS]
通讯作者: Kassab,GhassanS
Mathematical Model-Based Optimization of CRT Response in Ischemia
Mechanisms of coronary flow heterogeneity: Implications for coronary sinus occlusion therapy
Left Atrial Appendage Inversion to Prevent Stroke
  • 批准号:
    10006358
  • 项目类别:
  • 资助金额:
    $36.57万
  • 财政年份:
    2020
  • 负责人:
    GHASSAN S KASSAB
  • 依托单位:
New Access Kit for Lymphatic Interventions
  • 批准号:
    10079003
  • 项目类别:
  • 资助金额:
    $33.99万
  • 财政年份:
    2020
  • 负责人:
    GHASSAN S KASSAB
  • 依托单位:
海外基金